Glaxo says settles some Paxil birth-defect cases
Key points
- Drugmaker GlaxoSmithKline said on Tuesday it had agreed to settle certain U.S. lawsuits alleging its Paxil antidepressant caused birth defects in some patients but declined to put a figure on the settlements.
- "GSK has reached agreement to settle certain cases involving the use of Paxil during pregnancy.
- Three cases are scheduled for trial in Philadelphia in September," she added.
- "GSK considers options for every case, including settlement when it makes sense.
Drugmaker GlaxoSmithKline said on Tuesday it had agreed to settle certain U.S. lawsuits alleging its Paxil antidepressant caused birth defects in some patients but declined to put a figure on the settlements.
"GSK has reached agreement to settle certain cases involving the use of Paxil during pregnancy. The details of those settlements are confidential," spokeswoman Claire Brough said in an e-mailed statement.
"Other cases remain pending. Three cases are scheduled for trial in Philadelphia in September," she added.
"GSK considers options for every case, including settlement when it makes sense. The company has agreed to these settlements, despite its litigation defences, in order to avoid the costs, burdens and uncertainties of ongoing litigation."
Bloomberg News, citing people familiar with the settlements, earlier said the drugmaker had agreed to pay more than $1 billion to resolve more than 800 birth-defect cases related to Paxil.
News of the Paxil settlements comes after British-based Glaxo said last week it was taking a 1.57 billion-pound ($2.4 billion) legal charge to cover litigation related to Paxil, as well as to its diabetes pill Avandia and a former factory in Puerto Rico.
In the case of Paxil, the company said on July 15 that it had settled the "vast majority" of product liability cases.
--
LONDON (Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsProgressively reducing the nicotine content of cigarettes may not lead smokers to quit
The US Family Smoking Prevention and Tobacco Control Act, passed in 2009, permits the U.S. Food and Drug Administration (FDA) to set standards for cigarette nicotine content. The FDA is accordingly supporting research…
23 July 2015
NewsLow-nicotine cigarettes fail to sway smokers
Smokers who successfully lowered their nicotine intake when they were switched to low-nicotine cigarettes were unable to curb their smoking habits in the long term, according to a study by researchers at UCSF and San…
23 July 2015
NewsNo bones about it: Cannabis may be used to treat fractures
Cannabis - marijuana, hashish - was used as a go-to medical remedy by societies around the world for centuries. But the therapeutic use of marijuana was banned in most countries in the 1930s and '40s due to a growing…
18 July 2015
